FDA Approves Orexo Drug to Treat Opioid Addiction

Published July 4, 2013

FDA approves Orexo drug to treat opioid addiction
By Toni Clarke (Reuters) – The U.S. Food and Drug Administration has approved Swedish drugmaker Orexo AB’s drug to treat opioid addiction, the company said on Thursday, sending its shares up as much as 14.3 percent in Stockholm. The tablet, Zubsolv, dissolves under the tongue. It combines the drugs buprenorphine and naloxone and will compete with similar products, Subutex and Suboxone, made by …
Source